Posted in | News | Energy | Petrochemicals

Capacity Expansion Leads to World's Largest Paraxylene Production Facility

ExxonMobil Chemical today announced it will invest in an expansion of its Rotterdam Aromatics Plant. The expansion will make this world-scale plant ExxonMobil’s largest paraxylene production facility, increasing its paraxylene production capacity by 25 percent and benzene production capacity by 20 percent.

“This investment demonstrates ExxonMobil’s ongoing commitment to meet growing customer demand for these products and is part of the company’s strategy to develop world-scale, highly integrated chemical facilities with globally competitive cost structures,” said Matt Aguiar, Basic Chemicals Global Business vice president, ExxonMobil Chemical Company. “The new unit will benefit from integration with existing facilities and capture a number of synergies with the base plant.”

In addition, the new unit will employ ExxonMobil’s proprietary PxMaxSM technology to produce paraxylene and benzene. The PxMax process improves selectivity, generates less waste and reduces energy requirements versus existing technologies.

This expansion project, which will be owned and operated by ExxonMobil Chemical Holland B.V., is targeted to help meet growing European demand for paraxylene and benzene. Construction for the expansion project will commence this year.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.